Journals / Astım Allerji İmmünoloji / 2020 / Cilt: 18 - Sayı: 1

Does the Hyper IgM Phenotype Affect Prognosis in Ataxia Telangiectasia?

Pages
38–46
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The HIGM phenotype aggravates the clinical course of the disease resulting in fatalities at an earlier age and at a higher rate.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To evaluate the characteristics of the patients who were followed-up with the diagnosis of ataxia telangiectasia (AT) and to assess the relationship between the hyper IgM (HIGM) phenotype and their prognosis.Materials and Methods: From 2007 to 2019, the study included 68 patients aged 3-35 years who were followed-up with the diagnosis of AT.
📊
Key Findings & Data:Results: There were 36 girls and 32 boys with a median follow-up of 10 years (1-12 years).
💡
Conclusion & Impact:The HIGM phenotype aggravates the clinical course of the disease resulting in fatalities at an earlier age and at a higher rate.
🔬Design:Research Article
📍Scope:2007 Verileri
⚙️Variables:Domain Parameters

Özet

Objective: To evaluate the characteristics of the patients who were followed-up with the diagnosis of ataxia telangiectasia (AT) and to assess the relationship between the hyper IgM (HIGM) phenotype and their prognosis.Materials and Methods: From 2007 to 2019, the study included 68 patients aged 3-35 years who were followed-up with the diagnosis of AT. We retrospectively evaluated the clinical and immunological characteristics and follow-up results. Results: There were 36 girls and 32 boys with a median follow-up of 10 years (1-12 years). The most common complaints upon admission were unsteady walk in 87%, infection in 6%, presence of a family history in 6%, and intracranial mass in 1%. The marriage was consanguineous in 85% of the parents. Ataxia was seen in 100% of the patients, telangiectasia in 97%, and immune deficiency in 88%. Bronchiectasis was observed in 23.5% of the patients, chronic diarrhea in 19%, lymphoproliferation in 15%, malignancy in 10%, autoimmunity in 10%, liver failure in 6%, and granulomatous skin lesions in 6%. Thirteen patients (19%) died during follow-up. The HIGM phenotype was identified in 31% of the patients. Recurrent upper and lower respiratory tract infections (p=0.004 and p<0.0001, respectively), liver failure (p=0.005), and autoimmune diseases (p=0.023) were significantly higher in the HIGM (+) group than the HIGM (-) group. Life expectancy was shorter in the HIGM (+) group with 14 ± 0.73 years (CI 95% 12.55-15.44) compared to the HIGM (-) group with 18 ± 1.64 years (CI 95% 14.77-21.22) (p=0.054). Conclusion: During the early childhood period and before the characteristic findings of AT develop, the patients might present at a hospital with infections, autoimmunity, lymphoproliferation, or malignancy. Physical examination, high alpha-fetoprotein (AFP) levels and immunological testing provide important data for the correct diagnosis. The HIGM phenotype aggravates the clinical course of the disease resulting in fatalities at an earlier age and at a higher rate.

🔖

Cite This Article

HASKALOĞLU, Ş., BAL, S. K., ISLAMOĞLU, C., BASKIN, K., DOĞU, F., IKINCIOĞULLARI, A., AYTEKIN, C., YAVUZ, Z., ALTUN, D., CEYLANER, S. (2020). Does the Hyper IgM Phenotype Affect Prognosis in Ataxia Telangiectasia?. Astım Allerji İmmünoloji, Cilt: 18 - Sayı: 1, 38–46. https://ajindex.com/articles/141892

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Boder E, Sedgwick RP. A familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent pulmonary infection: A preliminary report on 7 children, an autopsy, and a case history. Univ Southern Calif Med Bull 1957; 9:15-28
  2. Gatti RA, Berkel I, Boder E, Braedt G, Charmley P, Concannon P, et al. Localization of an ataxia-telangiectasia gene to chromosome 11q22-2 3. Nature 1988;336:577-80
  3. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, et al. A single ataxia-telangiectasia gene with a product similar to PI-3 kinase. Science 1995;268:1749-53
  4. Savitsky K, Sfez S, Tagle D, Ziv Y, Sartiel A, Collins FS, et al. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum Mol Genet 1995;4:2025-32
  5. Chun HH, Gatti RA. Ataxia-telangiectasia, an evolving phenotype. DNA Repair (Amst) 2004;3(8-9):1187-96
  6. Moin M, Aghamohammadi A, Kouhi A, Tavassoli S, Rezaei N, Ghaffari SR, et al. Ataxia-telangiectasia in Iran: Clinical and laboratory features of 104 patients. Pediatr Neurol 2007;37(1):21-8. 7. van Os NJH, Jansen AFM, van Deuren M, Haraldsson A, van Driel NTM, Etzioni A, et al. Ataxia-telangiectasia: Immunodefciency and survival. Clin Immunol 2017; 178:45-55
  7. Bredemeyer AL, Huang CY, Walker LM, Bassing CH, Sleckman BP. Aberrant V(D)J recombination in ataxia telangiectasia mutated-deficient lymphocytes is dependent on nonhomologous DNA end joining. J Immunol 2008;15;181(4):2620-5
  8. Roifman CM, Gelfand EW. Heterogeneity of the immunological deficiency in ataxia-telangiectasia: Absence of a clinical-pathological correlation. Kroc Found Ser 1985;19:273-85
  9. Nowak-Wegrzyn A, Crawford TO, Winkelstein JA, Carson KA, Lederman HM. Immunodeficiency and infections in ataxia telangiectasia. J Pediatr 2004;144(4):505-11
  10. Ghiasy S, Parvaneh L, Azizi G, Sadri G, Zaki Dizaji M, Abolhassani H, et al. The clinical significance of complete class switching defect in Ataxia telangiectasia patients. Exp Rev Clin Immunol 2017;13:499-505
  11. Noordzij JG, Wulffraat NM, Haraldsson A, Meyts I, van’t Veer LJ, Hogervorst FB, et al. Ataxia-telangiectasia patients presenting with hyperIgM syndrome. Arch Dis Child 2009;94:448-9
  12. Aghamohammadi A, Imai K, Moazzami K, Abolhassani H, Tabatabaeiyan M, Parvaneh N, et al. Ataxia-telangiectasia in a patient presenting with hyperimmunoglobulin M syndrome. J Investig Allergol Clin Immunol 2010;20:442-5
  13. Etzioni A